These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 15781963)

  • 1. Orphanin FQ antagonizes the inhibition of Ca(2+) currents induced by mu-opioid receptors.
    Zhang M; Wang X; Zhang D; Xu G; Dong H; Yu Y; Han J
    J Mol Neurosci; 2005; 25(1):21-7. PubMed ID: 15781963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nociceptin/orphanin FQ and the opioid receptor-like ORL1 receptor.
    Meunier JC
    Eur J Pharmacol; 1997 Dec; 340(1):1-15. PubMed ID: 9527501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nociceptin/Orphanin-FQ Inhibits Gonadotropin-Releasing Hormone Neurons via G-Protein-Gated Inwardly Rectifying Potassium Channels.
    Constantin S; Wray S
    eNeuro; 2018; 5(6):. PubMed ID: 30627649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OFQ reverses the kappa-opioid receptor-mediated depression of calcium current in rat dorsal root ganglion neurons.
    Zhang M; Sun QL; Wan Y; Yao L; Yu YX; Han JS
    Neuroreport; 1998 Jun; 9(9):2095-8. PubMed ID: 9674600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential antagonism by naloxone benzoylhydrazone of the activation of inward rectifying K+ channels by nociceptin and a mu-opioid in rat periaqueductal grey slices.
    Chiou LC
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Jun; 363(6):583-9. PubMed ID: 11414652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nociceptin/orphanin FQ modulation of ionic conductances in rat basal forebrain neurons.
    Chin JH; Harris K; MacTavish D; Jhamandas JH
    J Pharmacol Exp Ther; 2002 Oct; 303(1):188-95. PubMed ID: 12235250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid-related (ORL1) receptors are enriched in a subpopulation of sensory neurons and prolonged activation produces no functional loss of surface N-type calcium channels.
    Murali SS; Napier IA; Rycroft BK; Christie MJ
    J Physiol; 2012 Apr; 590(7):1655-67. PubMed ID: 22371475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding and GTPgammaS autoradiographic analysis of preproorphanin precursor peptide products at the ORL1 and opioid receptors.
    Neal CR; Owens CE; Taylor LP; Hoversten MT; Akil H; Watson SJ
    J Chem Neuroanat; 2003 Jul; 25(4):233-47. PubMed ID: 12842269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nociceptin/orphanin FQ receptor expression in clinical pain disorders and functional effects in cultured neurons.
    Anand P; Yiangou Y; Anand U; Mukerji G; Sinisi M; Fox M; McQuillan A; Quick T; Korchev YE; Hein P
    Pain; 2016 Sep; 157(9):1960-1969. PubMed ID: 27127846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Actions of nociceptin/orphanin FQ and other prepronociceptin products on rat rostral ventromedial medulla neurons in vitro.
    Vaughan CW; Connor M; Jennings EA; Marinelli S; Allen RG; Christie MJ
    J Physiol; 2001 Aug; 534(Pt 3):849-59. PubMed ID: 11483714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orphanin FQ/nociceptin-mediated desensitization of opioid receptor-like 1 receptor and mu opioid receptors involves protein kinase C: a molecular mechanism for heterologous cross-talk.
    Mandyam CD; Thakker DR; Christensen JL; Standifer KM
    J Pharmacol Exp Ther; 2002 Aug; 302(2):502-9. PubMed ID: 12130708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nociceptin/orphanin FQ decreases serotonin efflux in the rat brain but in contrast to a kappa-opioid has no antagonistic effect on mu-opioid-induced increases in serotonin efflux.
    Tao R; Ma Z; Thakkar MM; McCarley RW; Auerbach SB
    Neuroscience; 2007 Jun; 147(1):106-16. PubMed ID: 17499930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence.
    Witkin JM; Statnick MA; Rorick-Kehn LM; Pintar JE; Ansonoff M; Chen Y; Tucker RC; Ciccocioppo R
    Pharmacol Ther; 2014 Mar; 141(3):283-99. PubMed ID: 24189487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orphanin FQ/nociceptin blocks chronic morphine-induced tyrosine hydroxylase upregulation.
    Thakker DR; Standifer KM
    Brain Res Mol Brain Res; 2002 Sep; 105(1-2):38-46. PubMed ID: 12399106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete knockout of the nociceptin/orphanin FQ receptor in the rat does not induce compensatory changes in mu, delta and kappa opioid receptors.
    Homberg JR; Mul JD; de Wit E; Cuppen E
    Neuroscience; 2009 Sep; 163(1):308-15. PubMed ID: 19527777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual coupling of opioid receptor-like (ORL1) receptors to adenylyl cyclase in the different layers of the rat main olfactory bulb.
    Onali P; Ingianni A; Olianas MC
    J Neurochem; 2001 Jun; 77(6):1520-30. PubMed ID: 11413235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Phe1psi(CH2-NH)Gly2]nociceptin-(1 - 13)-NH2 activation of an inward rectifier as a partial agonist of ORL1 receptors in rat periaqueductal gray.
    Chiou LC
    Br J Pharmacol; 1999 Sep; 128(1):103-7. PubMed ID: 10498840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative study of [Tyr10]nociceptin/orphanin FQ (1-11) at NOP receptors in rat periaqueductal gray and expressed NOP receptors in HEK293 cells.
    Liao YY; Lee CW; Ho IK; Chiou LC
    Life Sci; 2012 Feb; 90(7-8):306-12. PubMed ID: 22213115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1-Benzyl-N-[3-[spiroisobenzofuran-1(3H),4'-piperidin-1-yl]propyl]pyrrolidine-2-carboxamide (Compound 24) antagonizes NOP receptor-mediated potassium channel activation in rat periaqueductal gray slices.
    Liao YY; Trapella C; Chiou LC
    Eur J Pharmacol; 2009 Mar; 606(1-3):84-9. PubMed ID: 19374842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mu-opioid-induced desensitization of opioid receptor-like 1 and mu-opioid receptors: differential intracellular signaling determines receptor sensitivity.
    Mandyam CD; Thakker DR; Standifer KM
    J Pharmacol Exp Ther; 2003 Sep; 306(3):965-72. PubMed ID: 12750434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.